Funding · Company
ArriVent Biopharma, Inc.
Newtown Square, PABiotech & Pharma
ArriVent Biopharma, Inc. of Newtown Square, PA has disclosed $260M across 2 Form D offerings filed with the SEC between Feb 14, 2022 and Dec 29, 2022.
$260M
Total disclosed
2
Form D offerings
2021
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$110M
Form D · Dec 29, 2022 ↗
Q4 2022
· target $145M
Filing details
HeadquartersNewtown Square, PAIndustryBiotech & Pharma (Biotechnology)Incorporated2021SEC CIK0001868279Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →